Saleem Sadaf, Neema Asghar Mah E, Umer Abdullah, Ahmed Sofia, Adeel Muhammad Umair, Khan Humna, Hamza Muhammad, Jawad Sumbal
Dermatology, Sheikh Zayed Hospital, Lahore, PAK.
Dermatology, Bahawal Victoria Hospital, Bahawalpur, PAK.
Cureus. 2025 May 22;17(5):e84635. doi: 10.7759/cureus.84635. eCollection 2025 May.
Keloid is a benign hyper-proliferative growth of dermal fibroblasts, which extends beyond the borders of the original wound. It does not regress spontaneously and has the tendency to recur after excision.
To compare the efficacy of intralesional 5-fluorouracil (5-FU) alone versus intralesional 5-FU combined with triamcinolone acetonide (TCA) in the treatment of keloids.
This prospective observational study was conducted at the Department of Dermatology, Sheikh Zayed Hospital, Lahore, Pakistan, from July 2018 to July 2019. In this study, 66 cases, 33 in each group of aged 15-50 years having keloid of at least three or more on the Vancouver scar scale (VSS) score lasting less than five years, were included. The 66 patients were categorized into two equal groups. Group A was treated with 5-FU alone, and group B with 5-FU combined with TCA. Efficacy was defined as achieving a VSS score of 0 after eight weeks of treatment.
From the 66 patients, there were 19 (57.58%) males in group A and 15 (46.88%) in group B. There were a total of nine (27.27%) cases of diabetes mellitus (DM) in group A and eight (24.24%) in group B. There were 12 (36.36%) and 10 (30.30%) hypertensive cases in groups A and B, respectively. Compliance was 100% in both groups. Efficacy in group A was seen in 25 (75.76%) cases and 32 (96.97%) cases in group B, with a p-value of 0.02. This efficacy was significantly better in group B in terms of male gender, where it was seen in 100% of cases in group B compared to 13 (68.42%) of cases in group A, with a p-value of 0.02. There was no significant difference in terms of age groups, BMI, and hypertension (HTN). The efficacy in diabetics was nearly significantly better in group B, where it was seen in 100% of the cases (p = 0.08).
Both groups are efficacious for the treatment of keloid; however, the combination of 5-FU and TCA revealed greater efficacy, and it was significantly better than 5-FU alone. The results were again significantly better in terms of efficacy in the male gender and those who had keloids for more than one year.
瘢痕疙瘩是真皮成纤维细胞的良性过度增殖性生长,其超出原始伤口边界。它不会自发消退,切除后有复发倾向。
比较皮损内单独注射5-氟尿嘧啶(5-FU)与皮损内注射5-FU联合曲安奈德(TCA)治疗瘢痕疙瘩的疗效。
本前瞻性观察研究于2018年7月至2019年7月在巴基斯坦拉合尔谢赫扎耶德医院皮肤科进行。本研究纳入66例年龄在15 - 50岁、温哥华瘢痕量表(VSS)评分至少为三分及以上且瘢痕疙瘩持续时间少于五年的患者,分为两组,每组33例。66例患者被分为两组。A组单独使用5-FU治疗,B组使用5-FU联合TCA治疗。疗效定义为治疗八周后VSS评分为0。
66例患者中,A组有19例(57.58%)男性,B组有15例(46.88%)男性。A组共有9例(27.27%)糖尿病(DM)患者,B组有8例(24.24%)。A组和B组分别有12例(36.36%)和10例(30.30%)高血压患者。两组的依从性均为100%。A组25例(75.76%)患者有效,B组32例(96.97%)患者有效,p值为0.02。在男性患者中,B组的疗效显著更好,B组100%的病例有效,而A组为13例(68.42%),p值为0.02。在年龄组、体重指数和高血压方面无显著差异。B组糖尿病患者的疗效几乎显著更好,100%的病例有效(p = 0.08)。
两组对瘢痕疙瘩的治疗均有效;然而,5-FU与TCA联合使用显示出更大的疗效,且显著优于单独使用5-FU。在男性患者和瘢痕疙瘩病程超过一年的患者中,联合治疗的疗效结果同样显著更好。